Skip to main content
GILD
NASDAQ Life Sciences

FDA Clears Gilead's Sacituzumab Govitecan-Hziy for Two New Breast Cancer Indications

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$126.19
Mkt Cap
$156.674B
52W Low
$104.46
52W High
$157.29
52W Position info
21% above low
Off High info
20% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

GILD sits 21% above its 52-week low of $104.46.

Summary

The FDA has approved Gilead's Sacituzumab Govitecan-Hziy (Trodelvy) for two new indications in adults with triple-negative breast cancer, including as monotherapy in combination with Pembrolizumab for first-line treatment. This significant regulatory win expands the market for a key oncology drug, bolstering Gilead's position in the competitive cancer treatment landscape. The approval follows a period of substantial M&A activity and associated financing, indicating a strategic focus on strengthening its oncology pipeline.

At the time of this announcement, GILD was trading at $126.19 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $156.7B. The 52-week trading range was $104.46 to $157.29. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

GILD - Latest Insights

GILD
Nov 06, 2026, 12:16 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $167.82
Real-time Price: $168.16 info
Change: +$0.345 (+0.21%) info
Market Cap: $211.18B info
GILD
Nov 05, 2026, 10:35 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $174.57
Real-time Price: $168.16 info
Change: -$6.41 (-4%) info
Market Cap: $211.18B info
GILD
Oct 29, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $165.88
Real-time Price: $168.16 info
Change: +$2.28 (+1%) info
Market Cap: $211.18B info
GILD
Oct 29, 2026, 4:02 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $164.00
Real-time Price: $168.16 info
Change: +$4.16 (+3%) info
Market Cap: $211.18B info
GILD
Oct 22, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $157.19
Real-time Price: $168.16 info
Change: +$10.97 (+7%) info
Market Cap: $211.18B info